On July 3, 2020 Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense reported that Kineta will be presenting at multiple virtual investor events in July 2020 (Press release, Kineta, JUL 3, 2020, View Source;utm_medium=rss&utm_campaign=kineta-presents-at-july-2020-virtual-investor-events [SID1234561700]). Shawn Iadonato, Kineta Chief Executive Officer and Craig Philips, President, will present a corporate overview at the following events:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Opal Group ESG Investment Forum 2020
July 8th, 2020 at 12:00-12:20PM Pacific Time

The Moneyshow Accredited Investors Virtual Event
July 23, 2020 at 7:40-8:10AM Pacific time